3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
273
Sarcoma
41
Thoracic
40
Dermatologic
30
Breast
24
Genitourinary
15
Gastrointestinal
11
Lymphoid
9
Gynecologic
7
Other hematologic neoplasm
6
Head & Neck
4
Endocrine
3
NET
2
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
242
Leukemia, Myeloid, Acute
190
Leukemia
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
138
Precursor Cell Lymphoblastic Leukemia-Lymphoma
120
Myeloproliferative Disorders
88
Multiple Myeloma
84
Leukemia, Lymphocytic, Chronic, B-Cell
78
Lymphoma, Non-Hodgkin
76
Primary Myelofibrosis
72
Leukemia, Myelomonocytic, Chronic
68
Lymphoma
67
Hodgkin Disease
66
Leukemia, Myeloid, Chronic-Phase
55
Lymphoma, Mantle-Cell
50
Blast Crisis
49
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, Follicular
44
Leukemia, Myeloid, Accelerated Phase
44
Congenital Abnormalities
41
Lymphoma, B-Cell, Marginal Zone
40
Burkitt Lymphoma
40
Neoplasms, Plasma Cell
38
Lymphoma, Large-Cell, Immunoblastic
35
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
35
Polycythemia Vera
32
Hematologic Neoplasms
31
Myelodysplastic-Myeloproliferative Diseases
30
Lymphoma, T-Cell, Cutaneous
29
Anemia, Refractory, with Excess of Blasts
29
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Brain Neoplasms
×
Myeloid
×
Clear all
NCT02900248
2019-04-02
N1
CureOne
Terminated
23 enrolled